QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
OTCMKTS:ZLDPF

Zealand Pharma A/S - ZLDPF Stock Forecast, Price & News

$30.13
-0.44 (-1.44%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$30.02
▼
$30.13
50-Day Range
$25.46
▼
$30.57
52-Week Range
$11.14
▼
$30.57
Volume
650 shs
Average Volume
83 shs
Market Capitalization
$1.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ZLDPF stock logo

About Zealand Pharma A/S (OTCMKTS:ZLDPF) Stock

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company's pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark.

Receive ZLDPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

ZLDPF Stock News Headlines

February 2, 2023 | msn.com
Zorb New Zealand At The World's Largest Ball Rolling Park
February 1, 2023 | msn.com
New Zealand announces NZ$700,000 in additional flood support as cleanup begins
February 3, 2023 | PressReach (Ad)
Biotech Stock Alert
Read Small Pharma's depression clinical trial results.
December 30, 2022 | finance.yahoo.com
Total number of shares and voting rights in Zealand Pharma at December 30, 2022
November 30, 2022 | finance.yahoo.com
Total number of shares and voting rights in Zealand Pharma at November 30, 2022
November 12, 2022 | seekingalpha.com
ZLDPF Zealand Pharma A/S
November 1, 2022 | finance.yahoo.com
Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting
October 11, 2022 | finance.yahoo.com
Zealand Pharma major shareholder announcement: Polar Capital
February 3, 2023 | Investing Trends (Ad)
Elon Musk Claims Solar Will Soon Power the World
The world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
October 10, 2022 | finance.yahoo.com
Zealand Pharma major shareholder announcement: Van Herk Investments
October 4, 2022 | finance.yahoo.com
Zealand Pharma announces completion of a directed issue and private placement of 4,975,000 new ordinary shares raising gross proceeds of approx. DKK 786 million
October 4, 2022 | finance.yahoo.com
Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares
September 19, 2022 | finance.yahoo.com
Zealand Pharma Presents Data from Phase 3 Trial of Dasiglucagon in Congenital Hyperinsulinism at the 60th Annual ESPE Meeting
September 13, 2022 | finance.yahoo.com
Zealand Pharma grants warrants to employees in Denmark
September 7, 2022 | finance.yahoo.com
Zealand Pharma Announces Global License and Development Agreement with Novo Nordisk for ZEGALOGUE® (dasiglucagon)
August 31, 2022 | finance.yahoo.com
Total number of shares and voting rights in Zealand Pharma at August 31, 2022
August 24, 2022 | finance.yahoo.com
Zealand Pharma Appoints Henriette Wennicke as Chief Financial Officer
August 13, 2022 | msn.com
New Zealand central bank to carry on with 50bps hike in August: Reuters poll
August 12, 2022 | msn.com
New Zealand rescuers use buckets and towels in race to save stranded dolphins
August 11, 2022 | nasdaq.com
POLL-New Zealand central bank to carry on with 50bps hike in August
August 11, 2022 | msn.com
New Zeland's Fonterra says high-quality FTAs boost confidence to keep investing in Malaysia
August 9, 2022 | msn.com
Pfizer's Perth employees strike over pay
August 8, 2022 | msn.com
Australia’s Richest Postcode has Been Revealed and it’s NOT in Sydney or Melbourne
August 8, 2022 | benzinga.com
Zealand Pharma (OTC:ZLDPF), Analyst Ratings, Price Targets, Predictions
August 8, 2022 | msn.com
Several Auckland stores targeted by thieves overnight
August 8, 2022 | msn.com
New Zealand newspapers call for Foster's axing as resentment swells
August 7, 2022 | msn.com
Eliminating HIV is within our grasp
See More Headlines
Receive ZLDPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zealand Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

ZLDPF Company Calendar

Last Earnings
11/10/2022
Today
2/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Private households
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ZLDPF
Previous Symbol
NASDAQ:ZLDPF
CUSIP
N/A
CIK
N/A
Web
www.zealandpharma.com
Phone
45-8877-3600
Fax
45-8877-3898
Employees
355
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($3.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-161,990,000.00
Net Margins
-810.58%
Pretax Margin
-739.28%
Return on Equity
-162.39%
Return on Assets
-65.49%

Debt

Debt-to-Equity Ratio
1.01
Current Ratio
3.69
Quick Ratio
3.69

Sales & Book Value

Annual Sales
$46.54 million
Price / Sales
33.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
51,510,000
Free Float
N/A
Market Cap
$1.55 billion
Optionable
Not Optionable
Beta
0.68

Key Executives

  • Mr. Adam Sinding Steensberg M.D. (Age 49)
    Pres & CEO
    Comp: $733.86k
  • Ms. Henriette Wennicke
    Chief Financial Officer
  • Mr. Ivan Mourits Moller (Age 51)
    Chief Operating Officer
  • Lani Pollworth Morvan
    Investor Relations & Communications Officer
  • Mr. Mads Kronborg
    Head of Investor Relations & Communication
  • Mr. Ravinder Chahil
    Sr. VP & Gen. Counsel
  • Ms. Christina Sonnenborg Bredal (Age 38)
    Sr. VP and Global Head of People & Organization
  • Ms. Hanne Heidenheim Bak (Age 70)
    Sr. Project Director, R&D Operations Mang. and Employee Representative Director
  • Dr. Jens Damsgaard Mikkelsen M.D.
    Head of Molecular Pharmacology
  • Dr. Danilo Verge
    Head of Global Medical Affairs

Key Competitors

View All Competitors













ZLDPF Stock - Frequently Asked Questions

Should I buy or sell Zealand Pharma A/S stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Zealand Pharma A/S in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ZLDPF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZLDPF, but not buy additional shares or sell existing shares.
View ZLDPF analyst ratings or view top-rated stocks.

How have ZLDPF shares performed in 2023?

Zealand Pharma A/S's stock was trading at $28.18 at the beginning of the year. Since then, ZLDPF stock has increased by 6.9% and is now trading at $30.13.
View the best growth stocks for 2023 here.

How were Zealand Pharma A/S's earnings last quarter?

Zealand Pharma A/S (OTCMKTS:ZLDPF) issued its quarterly earnings data on Thursday, November, 10th. The company reported ($0.45) EPS for the quarter, beating analysts' consensus estimates of ($0.68) by $0.23. The firm earned $5.92 million during the quarter, compared to analyst estimates of $5.30 million. Zealand Pharma A/S had a negative net margin of 810.58% and a negative trailing twelve-month return on equity of 162.39%.

What is Zealand Pharma A/S's stock symbol?

Zealand Pharma A/S trades on the OTCMKTS under the ticker symbol "ZLDPF."

How do I buy shares of Zealand Pharma A/S?

Shares of ZLDPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zealand Pharma A/S's stock price today?

One share of ZLDPF stock can currently be purchased for approximately $30.13.

How much money does Zealand Pharma A/S make?

Zealand Pharma A/S (OTCMKTS:ZLDPF) has a market capitalization of $1.55 billion and generates $46.54 million in revenue each year. The company earns $-161,990,000.00 in net income (profit) each year or ($3.79) on an earnings per share basis.

How many employees does Zealand Pharma A/S have?

The company employs 355 workers across the globe.

How can I contact Zealand Pharma A/S?

Zealand Pharma A/S's mailing address is Sydmarken 11 Soborg, Copenhagen G7, 2860. The official website for the company is www.zealandpharma.com. The company can be reached via phone at 45-8877-3600, via email at investors@zealandpharma.com, or via fax at 45-8877-3898.

This page (OTCMKTS:ZLDPF) was last updated on 2/3/2023 by MarketBeat.com Staff